At a glance
ClinicalIndex Comparison RecordN/ACompleted· 38 enrolled
Drug / intervention
Neqstentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Coil Assisted Flow Diversion: A Prospective, Single Arm, Multi-center Study to Assess the Safety and Performance of Neqstent in Adjunctive Therapy (CAFI Study)
In Brief
A clinical study evaluating Neqstent for Intracranial Aneurysm. Completed, enrolled 38 participants across 7 sites in 5 countries.
Detailed Summary
Cerus Endovascular is sponsoring a prospective, single arm, multi-center study to document the safety and performance of Neqstent in adjunctive therapy. The purpose of the study is to document safety and performance of the Neqstent in adjunctive therapy in treatment for patients with intracranial aneurysms (IA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntracranial Aneurysm
CountriesAustria, Canada, Denmark, Germany, Switzerland
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedDec 2019
Enrollment StartJan 2020
Primary CompletionJun 2022
Study CompletionNov 2023
TodayJul 2026
First PostedDec 5, 2019
Enrollment StartJan 21, 2020
Primary CompletionJun 17, 2022
Study CompletionNov 1, 2023
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 6.6 years ago
Interventions
Neqstentdevice
Adjunctive device providing stable aneurysm neck coverage for the placement of embolization coils within the aneurysm sac and long term stable occlusion of the aneurysm.